Capital Analysts LLC’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-650
| Closed | -$74K | – | 831 |
|
|
2020
Q3 | $74K | Sell |
650
-650
| -50% | -$74K | 0.01% | 354 |
|
|
2020
Q2 | $146K | Sell |
1,300
-1,274
| -49% | -$143K | 0.02% | 244 |
|
|
2020
Q1 | $231K | Buy |
2,574
+600
| +30% | +$53.8K | 0.03% | 198 |
|
|
2019
Q4 | $213K | Hold |
1,974
| – | – | 0.02% | 232 |
|
|
2019
Q3 | $193K | Buy |
1,974
+57
| +3% | +$5.57K | 0.02% | 225 |
|
|
2019
Q2 | $251K | Buy |
1,917
+148
| +8% | +$19.4K | 0.03% | 206 |
|
|
2019
Q1 | $239K | Hold |
1,769
| – | – | 0.03% | 205 |
|
|
2018
Q4 | $172K | Hold |
1,769
| – | – | 0.02% | 209 |
|
|
2018
Q3 | $246K | Hold |
1,769
| – | – | 0.03% | 183 |
|
|
2018
Q2 | $220K | Hold |
1,769
| – | – | 0.03% | 191 |
|
|
2018
Q1 | $197K | Buy |
+1,769
| New | +$197K | 0.02% | 188 |
|